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Pigmented villonodular synovitis (PVNS) is an aggressive proliferative lesion that usually involves the synovial
tissues of big joints. To date, there are 52 cases of PVNS affecting the temporomandibular joint reported in the
English-language literature, about one-third of them exhibiting intracranial involvement. We herein describe an
additional case of PVNS of the temporomandibular joint with skull base invasion affecting a 26-year-old male patient
and discuss its clinicopathologic features considering previously published cases. Histopathology and imaging
evaluation are important for the diagnosis of PVNS, which should be included in the differential diagnosis of
preauricular aggressive swellings. (Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;111:e17-e28)Tumors and pseudotumors of the temporomandibular
joint (TMJ) are rare. The most common group include
arthritic changes (e.g., osteoarthritis and rheumatoid
arthritis), whereas neoplasms (e.g., osteochondroma,
chondroma, and osteoma) and synovial disease (e.g.,
synovial chondromatosis and pigmented villonodular
synovitis [PVNS]) are uncommon.1-3 PVNS is a rare
proliferative benign lesion with an incidence of 1.8
annual cases per million individuals, and which prefer-
entially affects the synovial tissue of the large joints,
such as the knee and hip of adult patients in their third
to fifth decades of life.4 It can involve any articular site,
including the ankle, shoulder, and elbow, and rarely
involves the joints of the hands, feet, spine, and TMJ.5
The most common features seen in patients with
PVNS affecting the TMJ region (PVNS-TMJ) include
preauricular swelling with progressive pain and mouth
opening restriction. Imaging examinations show impor-
tant bone destruction, and about one-third of the cases
present skull base involvement.6,7 Microscopically,
PVNS shows mononuclear and osteoclast-like multinu-
cleated giant cells distributed in a vascular fibrous
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doi:10.1016/j.tripleo.2010.11.019stroma, presenting villonodular proliferations and he-
mosiderin deposition.8
The first report of PVNS-TMJ is attributed to Lapay-
owker et al. in 1973, and to the best of our knowledge,
52 cases have been published in the English-language
literature (Table I), and at least 4 additional cases in
non-English languages.9-12 Herein, we report an addi-
tional case of PVNS-TMJ with skull base involvement
and review the literature.
CASE REPORT
A 26-year-old male patient was referred to the Oral and
Maxillofacial Surgery service in the city of Aracaju (Sergipe,
Brazil), complaining of difficulties in opening his mouth. It
was painless, but the patient reported a progressive loss of
hearing in his left ear, which started suddenly 2 months before
without any association with trauma or previous treatment.
His medical history was noncontributory. Extraoral examina-
tion revealed a painless diffuse swelling in the left preauric-
ular region measuring 0.5 cm and a slight facial asymmetry
on the left body of the mandible compared with the opposite
side (Fig. 1, A). There was an opening mouth restriction of 20
mm, without mandibular deviation.
Computerized tomography (CT) showed extensive bony
destruction of the left condyle and a mass measuring about
1.5 cm in diameter located in the left infratemporal fossa and
middle cranial fossa (Fig. 2). Magnetic resonance images
(MRI) were requested for better soft tissue evaluation, which
showed homogenous hypointensity throughout the lesion on
both T1- and T2-weighted sequences. The MRI analysis also
showed displacement of adjacent structures, such as the left
medial pterigoid muscle, masseter muscle, and left temporal
lobe, confirming the infiltrative nature of the lesion (Fig. 3).
Considering the imaging features of infiltrative and de-
structive growth, the main clinical differential diagnosis
was of osteosarcoma, chondrosarcoma, or metastatic dis-
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Table I. Clinical features of 52 cases of pigmented villonodular synovitis (PVNS) of the temporomandibular joint (TMJ) reported in the English-language
literature and the present case
Case Author Age (y)/gender Clinical features/duration BD IC Treatment
Recurrence/
follow-up
1-2 Lapayowker et al. (1973)41 22/M Preauricular swelling, pain when chewing/18 mo Yes No SE, partial capsulectomy NR
58/F Preauricular swelling, clicking, hearing decrease/1 y Yes No NR NR
3 Barnard (1975)61 37/M Painful preauricular swelling, trismus/3 wk Yes NR Conservative approach NR
4 Dinerman and Myers (1977)62 58/F Preauricular swelling, clicking, tinnitus, hearing
decrease/10 mo
Yes Yes SE, dura mater was excised No/4 y
5 Miyamoto et al. (1977)42 34/M Preauricular swelling, trismus/NR Yes No SE No/2 y
6 Raibley (1977)43* 62/F Painful preauricular swelling/2 y No No SE No/5 mo
7 Makek and Drommer (1978)17 55/F Painful preauricular swelling, trismus/18 mo Yes No SE, capsulectomy No/9 mo
8 Takagi and Ishikawa (1981)50* 36/M Clicking, trismus/3 y NR No SE, partial condylectomy Yes/16 y
9 Gallia et al. (1982)63 47/F Preauricular swelling, trismus, masticatory pain/3
wks
Yes No SE No/2 y
10 Rickert and Shapiro (1982)64 39/F Asymptomatic parotid mass/1 mo No No SE, partial capsulectomy NR
11 Curtin et al. (1983)35 47/F Facial painful swelling, trismus/18 mo Yes No SE NR
12 O’Sullivan et al. (1984)56 61/F Preauricular swelling/NR Yes Yes SE, radiotherapy Yes/3 y
13 Dawiskiba et al. (1989)47 32/M Painful preauricular swelling, trismus/NR No No NR NR
14 Eisig et al. (1992)19 50/F Ear canal mass, hearing loss/2 mo Yes Yes SE, condylectomy No/1 y
15 Syed et al. (1993)59 10/F Preauricular swelling/1 y No No SE, partial capsulectomy NR
16 Franchi et al. (1994)65 59/F Painful preauricular swelling/6 mo No No SE, partial capsulectomy No/1 y
17 Shapiro et al. (1996)66 36/M Painful preauricular swelling, clicking, hearing loss/
NR
Yes Yes SE No/18 mo
18 Youssef et al. (1996)67 41/F Painful preauricular swelling/6 mo Yes No SE, synovectomy No/14 mo
19 Allis-Montmayeur et al. (1997)1 39/F External ear canal mass/3 mo NR NR NR No/7 mo
20 Reñaga Rubin et al. (1997)27 70/F Painful preauricular swelling, clicking, trismus/7 mo Yes No SE, synovectomy No/3 y
21 Tanaka et al. (1997)25 47/M Painful preauricular swelling, trismus/8 mo Yes Yes SE, condylectomy, temporal
craniectomy
No/2 y
22 Yu et al. (1997)48 48/M Painful preauricular swelling/7 mo No No SE NR
23 Chow et al. (1998)68 42/F Zygomatic region swelling/6 mo Yes No SE, condylectomy, capsulectomy No/2 y
24 Omura et al. (1998)69 18/M Painful preauricular swelling, trismus/10 mo Yes No SE No/2 y
25 Bemporad et al. (1999)24 37/M Preauricular swelling, trismus, hearing loss/4 y Yes Yes SE, temporal craniectomy NR
26 Song et al. (1999)23 57/F Preauricular swelling/2 mo Yes No SE, condylectomy NR
27 Stojadinovic et al. (1999)26 63/M Painful preauricular swelling, trismus/2 y Yes Yes SE, condylectomy No/20 mo
28 Lee et al. (2000)18 59/F Preauricular swelling, salivary flow decreased/3 y Yes No SE, condylectomy No/2 y
29 Kis¸nis¸ci et al. (2001)28 45/F Painful preauricular swelling, trismus/NR No No SE, partial capsulectomy No/1 y
30 Klenoff et al. (2001)32 35/NR Painful preauricular swelling, trismus, tinnitus,
hearing loss/4 mo
Yes Yes SE, craniectomy, mandibulectomy NR
31 Shapiro et al. (2002)46 36/M Temporal mass, clicking, hearing loss/NR Yes Yes SE, craniectomy No/7 y
32-33 Church et al. (2003)36 42/M Preauricular swelling, clicking, hearing loss/4 mo Yes Yes SE, partial mandibulectomy No/3 y
33/M Painful preauricular mass, trismus/2 y Yes No SE, partial mandibulectomy, TMJ
excision
No/2 y
34 Heo et al. (2003)37 45/M Painful preauricular swelling, tinnitus, clicking,
trismus/17 mo
Yes No NR NR
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Table I. Continued
Case Author Age (y)/gender Clinical features/duration BD IC Treatment
Recurrence/
follow-up
35 Aoyama et al. (2004)31 33/M Painless preauricular swelling, clicking,
trismus/20 y
Yes Yes SE, condylectomy, middle cranial
fossa resection
No/2 y
36-39 Kim et al. (2004)6 28/F NR Yes Yes NR NR
22/M NR Yes Yes NR NR
47/M NR Yes No NR NR
58/F NR Yes No NR NR
40 Tosun et al. (2004)38 60/M Zygomatic painful swelling, trismus, chronic otitis
media/10 y
Yes Yes SE, condylectomy, craniectomy No/5 y
41 Cascone et al. (2005)39 38/F Preauricular swelling/NR No No SE, parotidectomy No/1 y
42-43 Stryjakowska et al. (2005)33 36/M Painful preauricular swelling, trismus, tinnitus,
hearing loss/6 mo
Yes Yes SE, intradural resection,
mandibulectomy
No/3 y
36/F Painful parotid swelling/4 mo Yes No SE, partial capsulectomy Yes/1 y
44-45 Oda et al. (2007)34† 52/M Tightness in his ear/10 mo Yes No SE No/11 mo
67/M Painful swelling of the cheek/3 mo Yes Yes SE No/7 y 3 mo
46 Cascone et al. (2008)70 78/M Painless preauricular mass/NR No No SE, partial synovectomy No/2 y
47 Chen et al. (2008)29 56/F Progressive hearing loss, temporal headache/4 mo Yes Yes SE, craniectomy, radiotherapy No/9 mo
48 Day et al. (2008)60 38/M Painful zygomatic mass, discomfort with
mastication/2 mo
Yes Yes SE, partial synovectomy No/3 mo
49 Cai et al. (2009)51* 21/F Painful preauricular swelling, clicking, trismus/3 mo No No SE No/13 mo
50 Herman et al. (2009)7 36/M Painful preauricular mass/12-18 mo Yes Yes SE, craniectomy No/11 y
51 Shkoukani et al. (2009)40 74/F Painful preauricular mass, moderate trismus/few mo Yes Yes SE, condylectomy, partial
mandibulectomy
No/NR
52 Leiggener et al. (2010)71 22/F Pain, trismus/6 mo Yes No SE, condylectomy No/3 y
53 Present case (2011) 26/M Painless preauricular swelling, hearing loss, trismus/
2 mo
Yes Yes SE, synovectomy, middle cranial fossa
resection, radiotherapy
No/18 mo
BD, bone destruction; IC, intracranial extension; SE, surgical excision; NR, not reported.
*PVNS associated with synovial chondromatosis.
†PVNS presenting chondroid metaplasia.
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e20 Romañach et al. March 2011ease. A biopsy was performed through a preauricular ac-
cess, under general anesthesia. The intraoperative view
showed partial condylar destruction and a brown-reddish
fibrous mass presenting a spongiotic appearance in its
central area (Fig. 1, B).
Microscopic analysis showed nests of large and small
epithelioid mononuclear cells that had infiltrated the cortical
bone of the condyle. These nests were involved with a cellular
fibrous tissue and also contained a few osteoclast-like multi-
nucleated giant cells, blood vessels, and areas of hemorrhage
(Fig. 4, A). The mononuclear cells presented displaced ovoid
or angle-shaped nuclei and an abundant eosinophilic cyto-
plasm, with some containing pigmented granules, which were
Fig. 1. A, Patient with pigmented villonodular synovitis of t
and a slight asymmetry of the left mandible body and ramus.
of fibrous tissue with a spongiotic appearance in its central p
Fig. 2. Computerized tomography. A, Partial destruction of th
axial cut, bone window). B, Involvement of the temporal and
mass causing erosion of the internal surface of the left condy
cranial fossa (arrows, coronal cut, soft tissue window).initially interpreted as melanin or hemosiderin (Fig. 4, F). Themononuclear epithelioid cells were randomly disposed in a
fibrous or hyalinized stroma, forming nodular areas contain-
ing an osteoid-like material (Fig. 4, B-D). Abundant extra-
cellular pigmented granules were also seen in the stroma (Fig.
4, E). The Fontana-Masson stain was negative, but Perl’s iron
stained the granules deeply, confirming that the brownish
extra- and intracytoplasmic granules were hemosiderin (Fig.
5, A and B). Additionally, immunohistochemistry was per-
formed using antibodies against vimentin (Vim3B4, 1:400;
Dako, Glostrup, Denmark), S-100 protein (polyclonal,
1:10.000; Dako), HMB-45 (1:200, Dako), and CD68 (PG-
M1, 1:400, Dako). Osteoclast-like multinucleated giant cells
and some mononuclear cells showed strong granular cyto-
poromandibular joint showing discrete preauricular swelling
nsoperative view showing condylar destruction and presence
.
condyle and a hypodense mass in the left TMJ region (arrow,
id bones (arrows, coronal cut, bone window). C, Hyperdense
the petrous part of the temporal bone, infiltrating the medialhe tem
B, Trae left
spheno
le andplasmic reactivity with CD68 (Fig. 5, C), whereas vimentin
corona
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Volume 111, Number 3 Romañach et al. e21was homogeneously positive (Fig. 5, D). S-100 protein and
HMB-45 were negative. The final diagnosis was PVNS-TMJ.
The patient was treated surgically, but during the procedure
infratemporal destruction and infiltration of the dura mater
was observed. Because of the diffuse growth pattern, postop-
erative radiotherapy was carried out using 40 Gy in 20 frac-
tions. In addition to moderate dermatitis and eye irritation, the
patient developed postsurgical facial paralysis (Fig. 6). At the
time of writing, the patient exhibited preserved visual sharp-
ness, stable and painless mandibular excursion with 30 mm
mouth aperture, and improvement of the postoperative paral-
ysis of the frontal and zygomatic branches of the facial nerve.
There were no clinical or imaging signs of recurrence after 18
months of follow-up.
DISCUSSION
PVNS is a potentially aggressive proliferative lesion
that involves the synovial tissues of the joints, tendon
sheath, and bursa.13 The first report of PVNS is attrib-
uted to Chassaignac in 1852, who described it as a
nodular lesion of the middle finger.5 In 1941, Jaffe et al.
introduced the term PVNS for lesions showing hemo-
siderin and villonodular proliferation.14 They also pro-
posed the term pigmented villonodular bursitis/teno-
synovitis for microscopically similar lesions that
clearly affected the extra-articular bursa and tendons,
respectively.5,14
In the current World Health Organization (WHO)
classification,15 the family of giant cell tumors of the
tendon sheath (GCTTS) presents subtypes according to
their growth pattern (localized or diffuse) and site (in-
tra- or extra-articular). Localized GCTTS involves only
part of the synovium, showing pediculated or sessile
nodules, which commonly affects the fingers. Diffuse-
type GCTTS involves the whole synovial membrane
and adjacent structures, preferentially of the knee and
hip joints of young patients.15 Although the current
WHO classification uses the term diffuse-type GCTTS
Fig. 3. Magnetic resonance imaging. A, Coronal T2-weightin
including dura mater and medial and lateral pterygoid muscle
signal in close proximity to the adjacent dura mater (arrow,as a synonym of PVNS, other authors prefer to considerPVNS as a general designation that includes the local-
ized and diffuse subtypes, both with the possibility of
intra- or extra-articular presentation.5,13,15,16 Even
though some authors have also considered the localized
and diffuse subtypes as different stages of the same
lesion, the distinction is important, because diffuse
lesions tend to be more aggressive with a less favorable
prognosis.13,17,18
PVNS has been associated with reactive, inflamma-
tory, or traumatic origin, involving local hemorrhages
and/or local alterations of lipids.13,18,19 On the other
hand, the continuous growth and very aggressive bio-
logic behavior of these lesions resemble a true neopla-
sia. Trisomy of chromosomes 5 and 7, and a clustering
of structural rearrangements in chromosome 1 (1p11-
13), where the colony-stimulating factor 1 gene is lo-
cated, were described in localized and diffuse-type
PVNS, suggesting a neoplastic origin.13,20-22
To date, 52 cases of PVNS-TMJ have been reported
in the English-language literature (Table I), of which 25
were male, 26 female, and 1 in which gender was not
reported. Ages have ranged from 10 to 78 years old
(mean age 44 years), with the majority of cases occur-
ring in young adult patients in the fourth decade of life
(Fig. 7). Clinically, PVNS-TMJ is characterized by
preauricular swelling with a slow diffuse growth
pattern, progressive pain, and trismus, including
mouth opening restriction and discomfort in masti-
cation.7 A minority of patients have shown impaired
hearing, clicking, and tinnitus (Fig. 8). The patient
reported here was only 26 years old and presented a
shorter duration of symptoms than most reported
cases of PVNS-TMJ.
Clinical diagnosis of PVNS is difficult, but CT and
MRI proved to be very helpful in the diagnosis and
treatment plan, showing extension of the lesion as well
wing a low-signal lesion compressing the adjacent structures,
ows). B, The lesion also displays some areas of intermediate
l T1-weighting with contrast).g, sho
s (arras bone destruction.23,24 Usually, CT of PVNS with
OOOOE
e22 Romañach et al. March 2011high iron content shows a high-density noncalcifying
soft tissue mass that might cause erosion or extensive
destruction of the condyle, temporal bone, and infra-
temporal fossa. In some cases, there is an expansive
lesional invasion into the middle cranial fossa that
compresses but does not infiltrate the dura ma-
ter.6,7,19,25,26 MRI is the best ancillary technique to
Fig. 4. Histologic aspects of pigmented villonodular synov
epithelioid appearance and osteoclast-like multinucleated gia
(hematoxylin-eosin [HE], original magnification 100). B, M
100). C, In some areas the stroma is more fibrous, compr
nodules mimicking osteoid (HE,100). E, Diffuse pigmentat
deposition after hemorrhagic episodes (HE, 100). F, Hemo
a characteristic epithelioid appearance (HE, 400).diagnose PVNS, characteristically presenting a specificfinding of low to intermediate signal in both T1- and
T2-weighted images.6,27-30 The MRI low signal inten-
sity areas of PVNS are best seen in T2-weighted images
and are attributed to a paramagnetic effect produced by
the reaction with iron, owing to the high quantity of
hemosiderin.4,6,13,31 The presence of hemosiderin caus-
ing the low signal intensity in MRI is also known as the
the temporomandibular joint. A, Mononuclear cells with
ls organized in nests that infiltrate the normal cortical bone
uclear cells randomly distributed in the fibrous stroma (HE,
the mononuclear cells (HE, 100). D, Presence of fibrous
he stroma is easily recognized, a consequence of hemosiderin
granules in the cytoplasm of mononuclear cells, which haveitis of
nt cel
onon
essing
ion of t
siderin“blooming effect” and is considered to be pathogno-
ral de
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Volume 111, Number 3 Romañach et al. e23monic of PVNS.5 Nevertheless, the presence of lipids
in xanthomatous macrophages and cystic areas can
Fig. 5. A, Mononuclear cells presenting intracytoplasmic he
Hemosiderin granules characteristically disposed at the perip
multinucleated giant cells positive for CD68 (immunohist
(immunohistochemistry, 400).
Fig. 6. Clinical aspect of the patient 6 months after surgic
synovitis of the temporomandibular joint, showing the tempoproduce high signal in T1- and T2-weighted images,respectively.29 Fifty reported cases of PVNS-TMJ
described bone destruction, 40 (80%) of them con-
erin granules (Perl’s stain, original magnification 400). B,
f the cytoplasm (Perl’s stain, 1,000). C, Mononuclear and
istry, 400). D, Mononuclear cells positive for vimentin
ision and adjuvant radiotherapy of pigmented villonodular
fect: A, frontal view; B, side view.mosid
hery o
ochemal excsisted of a diffuse osteolytic lesion, and, interest-
OOOOE
e24 Romañach et al. March 2011ingly, one-half of these cases exhibited intracranial
involvement highlighted by imaging examinations.
We also observed the typical imaging findings of
PVNS-TMJ, including the intracranial extension and
Fig. 7. Age distribution in decades of life of 52 cases of
published in the English-language literature.
Fig. 8. Prevalence of main clinical features of 48 pigmented
the English-language literature.the close proximity with the dura mater.The main clinical differential diagnosis of PVNS-
TMJ includes benign or malignant parotid tumors as
well as other lesions that affect the synovium and
adjacent structures, including rheumatoid arthritis, tu-
nted villonodular synovitis of the temporomandibular joint
odular synovitis of the temporomandibular joint published inpigmevillonberculosis, synovial hemangioma, synovial osteochon-
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thy, chondroma, osteochondroma, gout, tophaceous
pseudogout, chronic osteomyelitis, serous otitis media,
central giant cell lesion, sarcomas, and metasta-
sis.1,28,32-34 Only 31 out of the 52 PVNS-TMJ cases
(59%) included a possible differential diagnosis, but in
7 (13%) PVNS was included in the differential diag-
nosis,24,35-40 whereas 5 (9%) proposed the diagnosis of
malignant or metastatic disease.31,40-43 The clinical and
imaging features prompted us to propose the diagnostic
hypothesis of malignant neoplasia or metastasis in the
present case. Even though the TMJ region is an uncom-
mon site for malignant neoplasias, preauricular swell-
ings are more commonly malignant, including adenoid
cystic carcinoma, mucoepidermoid carcinoma, malig-
nant lymphoma, melanoma, squamous cell carcinoma,
chondrosarcoma, synovial sarcoma, osteosarcoma, and
fibrosarcoma.2,26,37 Metastatic tumors affecting the
TMJ region are extremely rare, and the most common
primary sites are breast and lung, even though prostate,
rectum, stomach, uterus, and pancreas have also been
reported in the literature.26,44,45
Fine needle aspiration cytology (FNAC) is an im-
portant approach to discard the diagnosis of a ma-
lignant neoplasia and can in fact help in the diagnosis
of PVNS.46 Only 8 PVNS-TMJ cases (15%) were
reported using FNAC for diagnostic purposes, which
on the cytopathologic examination showed mononu-
clear cells and multinucleated giant cells containing
hemosiderin pigments, similarly to other lesions
such as central giant cell lesion and chondroblas-
toma.24,25,36,38,40,46-49 FNAC was not performed in
the present case.
Macroscopically, PVNS shows increased thickness
of the synovium, a nodular growth pattern with villous
formation, and a rusty brownish color due to hemosid-
erin deposition.29,31,41 As in the present case, the loss of
the typical villous feature in PVNS-TMJ is common,
probably owing to its predominantly diffuse growth
pattern.15
Microscopically, PVNS presents synovial hyperpla-
sia with villous projections covered by multiple layers
of synovial cells. The cellular types include large and
small mononuclear cells, osteoclast-like multinucleated
giant cells and xanthomatous macrophages, which are
found in a vascularized fibrous stroma showing fusi-
form to polygonal stromal cells and intra- and extra-
cytoplasmic deposition of hemosiderin.8,33,34 The fi-
brous stroma can also show cleft-like spaces and
hyaline nodular formation mimicking osteoid mate-
rial, which are more evident in extra-articular areas.8
Mononuclear cells are distributed in nests or ran-
domly, displaying hemosiderin granules, which might
be shown by staining methods for iron, such as Perl’sPrussian blue.8,24,30,31,34 Although mitoses and cellular
atypia are absent, mononuclear cells might predomi-
nate, suggesting a sarcoma, especially in cases with
scarce osteoclast-like multinucleated giant cells.31 In
fact, our first microscopic impression was of a malig-
nant neoplasm, most likely an osteosarcoma or a mel-
anoma with epithelioid features. Nodular areas showed
osteoid-like formation that at first glance could be ma-
lignant; on the other hand, the pigmented cells could be
confused with malignant melanocytes. Melanoma was
ruled out because the pigment was positive for iron and
cells were negative for S-100 and HMB-45. Immuno-
histochemistry is not essential to diagnose PVNS, but
in certain cases it helps to rule out other possible
diagnoses.
It is interesting to mention reports of PVNS-TMJ
cases showing simultaneous occurrence with synovial
chondromatosis43,50,51 and chondroid metaplasia.34
There are also reports of PVNS showing features of
malignancy,52-54 but in the present case, anaplasia, mi-
totic figures, and necrotic areas were not detected.
The standard treatment for PVNS is surgery, with
partial or complete excision of the synovium and in-
volved bones.18 The surgical procedure of knee lesions
is usually done by arthroscopy. Some aggressive dif-
fuse PVNS cases have been treated by surgery followed
by low doses of radiotherapy.55 Recurrences occur
when surgical excision is incomplete and there is dif-
fuse involvement of the adjacent structures. In fact,
radiotherapy has been suggested for these recurrent
cases as well as for extensive cases which probably
could recur.33,56,57 Adjuvant radiotherapy is adminis-
tered 2 months after surgery, in 15-25 fractions with
doses ranging from 20 to 50 Gy.5,55,57 Even though the
efficacy of bisphosphonates has not been reported in
any case of PVNS-TMJ so far, Namazi58 considered
bisphosphonate as a novel possibility for PVNS treat-
ment because of its property of osteoprotegerin stimu-
lation, which can lead to a reduction of receptor acti-
vator of nuclear factor kappa B ligand and osteoclast
recruitment. Facial paralysis has been described as a
common postsurgical complication,39,59 but facial
nerve function can be completely recovered a few
months after surgery,59 as seen in the present case.
Follow-up should be made for 5-10 years after the
surgical procedure, including periodic CT and MRI
examinations.
All reported PVNS-TMJ cases have been treated by
surgical excision, and in 2 cases adjuvant radiotherapy
was performed.29,56 As noted above, PVNS-TMJ can
invade the cranial base and compress the dura mater,
making necessary the participation of a neurosurgeon
on the surgical team.7,29,38,60 In only 2 PVNS-TMJ
cases was adjuvant radiotherapy used, one for an unre-
OOOOE
e26 Romañach et al. March 2011sectable lesion56 and another for an extensive lesion
involving vital structures.29 Recurrence data were
available in 36 PVNS-TMJ cases, and only in 3 (8%) of
them was recurrence reported.33,50,56 The median fol-
low-up period was 2 years 9 months (range 3 months to
16 years). In the present case, the association of surgery
and low doses of radiotherapy has shown good results
so far.
In summary, PVNS is an uncommon proliferative
benign lesion of the TMJ with aggressive potential and
should be included in the differential diagnosis of
preauricular swellings, especially when accompanied
by mouth aperture and hearing difficulties. CT and MRI
are helpful for diagnosis, treatment, and follow-up.
Clinicians and oral pathologists should keep in mind
the possibility of PVNS when aggressive lesions in-
volve the TMJ, causing preauricular swelling.
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